SCHEDULE 13/G FILING BY CYCLERION ON BEHALF OF MFN PARTNERS

Company

Cyclerion Therapeutics, Inc.

Filed

February 12, 2021

Accession Number

0000904454-21-000194

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →